Personalis, Inc.

NASDAQ:PSNL

Medical - Diagnostics & Research

Healthcare
$14.98 +3.44%

+$0.34 today

Market cap
$1.62B
Beta
2.28
P/E (TTM)
-11.0
EPS (TTM)
-$0.92
52W Low $3.84High $12.53

Volume 1.47M

Average 2.31M

PSNL Total Equity

Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.

Personalis, Inc.NASDAQ: PSNL

Total Equity · Q1 FY2026 · quarter ended Mar 2026

Total equity rises 22.9% from a year ago

Total equity stood at $254.77M at the end of Q1 FY2026, up 22.9% from a year earlier and down 2.5% from the prior quarter. Over 3 fiscal years it compounded at +6.2% a year.

Context

  • Total equity amounted to 78.3% of total assets at the end of Q1 FY2026, up 2.4 pp from a year earlier.
  • Total equity increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether total equity keeps rising in the next quarterly balance sheet after a +22.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$254.77M-2.5% QoQ
Last fiscal yearDec 2025
$261.19M+28.7% YoY
Year agoMar 2025
$207.35M+22.9% since
Total Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+22.9%——
1 year+28.7%——
3-year CAGR+6.2%——
5-year CAGR——
10-year CAGR——

Total Equity history

USD · from the balance sheet

Latest · FY2025
261.19M USD
Year-over-year change
+28.7%
4-year CAGR
-4.2%

Total Equity vs competitors

How PSNL compares with its peers on the latest reported figures

  • PSNL's Mar 2026 total equity of $254.77M is the 8th highest of the 10 companies compared; the peer median is $785.73M.
  • Its year-over-year change of +22.9% is the 3rd highest of 10, against a peer median of +9.9%.
  • Total equity amounts to 78.3% of total assets for PSNL, versus a peer median of 68.5%.
PSNL Competitors Peer median
Total Equity for PSNL and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
GRALGRAIL, Inc.Jun 2026$2.54B +9.9%-17.8%89.4%
NTRANatera, Inc.Jun 2026$1.82B +46.2%+34.4%68.5%
VCYTVeracyte, Inc.Jun 2026$1.39B +13.7%+6.8%93.4%
FLGTFulgent Genetics, Inc.Mar 2026$1.04B -7.0%-4.5%90.3%
NEONeoGenomics, Inc.Jun 2026$785.73M -8.0%-5.7%58.1%
BLLNBillionToOne, Inc.Jun 2026$536.81M +217.3%—73.6%
MYGNMyriad Genetics, Inc.Mar 2026$337.4M -52.1%-25.4%50.1%
PSNLPersonalis, Inc.Mar 2026$254.77M +22.9%+6.2%78.3%
WGSGeneDx Holdings Corp.Jun 2026$244.22M -11.9%+6.7%50.7%
GHGuardant Health, Inc.Sep 2026-$275.9M +22.2%—14.6%
Peer median (excluding PSNL) $785.73M+9.9%-4.5%68.5%

Competitors are the stored peer set for PSNL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents105.59M89.13M56.98M91.42M124.25M
Short-term Investments181.48M78.53M57.2M93.59M115.71M
Net Receivables18.47M16.64M17.73M8.14M16.2M
Inventory4.08M6.38M5.66M3.98M6.14M
Other Current Assets1.53M9.02M9.17M5.89M5.65M
Total Current Assets318.23M199.7M146.74M203.02M267.95M
Property, Plant & Equipment (Net)73.47M88.42M75.22M64.73M59.93M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets4.83M4.59M3.14M2.53M6.28M
Total Non-current Assets78.3M93M78.36M67.25M66.21M
Total Assets396.53M292.7M225.1M270.27M334.16M
Account Payables9.22M12.85M14.92M6.4M12.99M
Short-term Debt1.81M2.22M1.65M1.67M1.19M
Tax Payables121K123K37K00
Deferred Revenue4.36M1.29M3.29M3.1M1.56M
Other Current Liabilities11.19M9.55M19.62M10.86M12.8M
Total Current Liabilities31.31M33.13M47.23M31.13M39.63M
Long-term Debt000031.87M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities2.12M389K10.1M1.3M1.48M
Total Non-current Liabilities54.91M41.43M48.42M36.19M33.35M
Total Liabilities86.23M74.56M95.66M67.31M72.98M
Common Stock4K5K5K9K10K
Retained Earnings(247.1M)(360.41M)(468.71M)(549.99M)(631.26M)
Accumulated OCI(166K)(912K)(222K)(23K)104K
Other Stockholders Equity00000
Minority Interest00000
Total Equity310.3M218.14M129.44M202.96M261.19M
Total Debt58.33M48.65M47.73M44.25M39.95M
Net Debt(47.25M)(40.48M)(9.26M)(47.17M)(84.3M)

Personalis, Inc.

NASDAQ:PSNL

Intrinsic Alpha fair value

Locked

Current Price

$14.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.